Age-dependent association between the Q7R polymorphism in the Saitohin gene and sporadic Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 16, Issue 3, 2003, Pages 132-135

  Combarros, Onofre ^a   Rodero, Lucía ^a   Infante, Jon ^a   Palacio, Enrique ^a   Llorca, Javier ^b   Fernández Viadero, Carlos ^c   Peña, Nicolás ^c   Berciano, José ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c Consejería de Sanidad ^*  (Spain)

Author keywords

Alzheimer's disease; Gene polymorphism; Saitohin; Tau

Indexed keywords

M PROTEIN; SAITOHIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CODON; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS;

AGE OF ONSET; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CODON; FEMALE; GENE DOSAGE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; TAU PROTEINS;

EID: 0038307227     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071000     Document Type: Article

References (26)

1. Hardy J, Duff K, Hardy KG, Perez-Tur J, Hutton M: Genetic dissection of Alzheimer's disease and related dementias: Amyloid and its relationship to tau. Nat Neurosci 1998;1:355-358.
2. Lee VMY: Biomedicine. Tauists and β-aptists united - well almost! Science 2001;293:1446-1447.
3. Mudher A, Lovestone S: Alzheimer's disease - Do tauists and β-aptists finally shake hands? Trends Neurosci 2002;25:22-26.
4. Trojanowski JQ: Tauists, β-aptists, syners, apostates, and new data. Ann Neurol 2002;52:263-265.
5. Heutink P: Untangling tau-related dementia. Hum Mol Genet 2000;9:979-986.
6. Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, St. George-Hyslop P, Munoz DG, Mann D, Lang AE, Bergeron C, Bigio EH, Litvan I, Bhatia KP, Dickson D, Wood NW, Hutton M: Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 2001;56:1702-1706.
7. Lilius L, Fabre SF, Basun H, Forsell C, Axelman K, Mattila K, Andreadis A, Viitanen M, Winblad B, Fratiglioni L, Lannfelt L: Tau gene polymorphisms and apolipoprotein E ε4 may interact to increase risk for Alzheimer's disease. Neurosci Lett 1999;277:29-32.
8. Roks G, Dermaut B, Heutink P, Julliams A, Backhovens H, Van de Broeck M, Serneels S, Hofman A, Van Broeckhoven C, van Duijn CM, Cruts M: Mutation screening of the tau gene in patients with early-onset Alzheimer's disease. Neurosci Lett 1999;277:137-139.
9. Kwon JM, Nowotny P, Shah PK, Chakraverty S, Norton J, Morris JC, Goate AM: Tau polymorphisms are not associated with Alzheimer's disease. Neurosci Lett 2000;284:77-80.
10. Baker M, Graff-Radford D, DeVriéze FW, Graff-Radford N, Petersen RC, Kokmen E, Boeve B, Myllykangas L, Polvikoski T, Sulkava R, Verkoniemmi A, Tienari P, Haltia M, Hardy J, Hutton M, Perez-Tur J: No association between TAU haplotype and Alzheimer's disease in population or clinic-based series or in familial disease. Neurosci Lett 2000;285:147-149.
11. Russ C, Powell JF, Zhao J, Baker M, Hutton M, Crawford F, Mullan M, Roks G, Cruts M, Lovestone S: The microtubule-associated protein Tau gene and Alzheimer's disease - An association study and meta-analysis. Neurosci Lett 2001;314:92-96.
12. Green EK, Thaker U, McDonagh AM, Iwatsubo T, Lambert JC, Chartier-Harlin MC, Harris JM, Pickering-Brown SM, Lendon CL, Mann DMA: A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain. Neurosci Lett 2002;324:113-116.
13. Crawford F, Freeman M, Town T, Fallin D, Gold M, Duara R, Mullan M: No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic- or population-based samples. Neurosci Lett 1999;266:193-196.
14. Bullido MJ, Aldudo J, Frank A, Coria F, Avila J, Valdivieso F: A polymorphism in the tau gene associated with risk for Alzheimer's disease. Neurosci Lett 2000;278:49-52.
15. Conrad C, Vianna C, Freeman M, Davies P: A polymorphic gene nested within an intron of the tau gene: Implications for Alzheimer's disease. Proc Natl Acad Sci USA 2002;99:7751-7756.
16. Cook L, Brayne CE, Easton D, Evans JG, Xuereb J, Cairns NJ, Rubinsztein DC: No evidence for an association between Saitohin Q7R polymorphism and Alzheimer's disease. Ann Neurol 2002;52:690-691.
17. Verpillat P, Ricard S, Hannequin D, Dubois B, Bou J, Camuzat A, Pradier L, Frebourg T, Brice A, Clerget-Darpoux F, Deleuze JF, Campion D: Is the Saitohin gene involved in neurodegenerative diseases? Ann Neurol 2002;52:829-832.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer Disease. Neurology 1984;24:939-944.
19. Frisoni G, Manfredi M, Geroldi C, Binetti G, Zanetti O, Bianchetti A, Trabucchi M: The prevalence of apoE-ε4 in Alzheimer's disease is age dependent. J Neurol Neurosurg Psychiatry 1998;65:103-106.
20. Lehmann DJ, Williams J, McBroom J, Smith AD: Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups. Neuroscience 2001;108:541-554.
21. Alvarez V, Alvarez R, Lahoz CH, Martínez C, Peña J, Guisasola LM, Salas-Puig J, Morís G, Uría D, Menes BB, Ribacoba R, Vidal JA, Sánchez JM, Coto E: Association between an α(2) macroglobulin DNA polymorphism and late-onset Alzheimer's disease. Biochem Biophys Res Commun 1999;264:48-50.
22. Crawford FC, Freeman MJ, Schinka JA, Abdullah LI, Gold M, Hartman R, Krivian K, Morris MD, Richards D, Duara R, Anand R, Mullan MJ: A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease. Neurology 2000;55:763-768.
23. Sheu KFR, Brown AM, Haroutunian V, Kristal BS, Thaler H, Lesser M, Kalaria RN, Relkin NR, Mohs RC, Lilius L, Lannfelt L, Blass JP: Modulation by DLST of the genetic risk of Alzheimer's disease in a very elderly population. Ann Neurol 1999;45:48-53.
24. Lambert JC, Mann DMA, Harris JM, Chartier-Harlin MC, Cummings A, Coates J, Lemmon H, St. Clair D, Iwatsubo H, Lendon C: The -48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Aβ load in brain. J Med Genet 2001;38:353-355.
25. Feuk L, Prince JA, Breen G, Emahazion T, Carothers A, St Clair D, Brookes J: Apolipoprotein-E dependent role for the FAS receptor in early onset Alzheimer's disease: Finding of a positive association for a polymorphism in the TNFRSF6 gene. Hum Genet 2000;107:391-396.
26. Payami H, Kaye J, Becker W, Norman D, Wetzsteon P: HLA-A2, or a closely linked gene, confers susceptibility to early-onset sporadic Alzheimer's disease in men. Neurology 1991;41:1544-1548.